The Simcyp population-based ADME simulator is a modelling and simulation platform used by the pharmaceutical industry in drug discovery and development. The Simulator models drug absorption, distribution, metabolism and elimination (ADME) using routinely generated in vitro data.
Simcyp simulations are performed in virtual populations, including paediatric populations, rather than an average individual. This allows individuals at extreme risk from adverse reaction to be identified prior to human studies.[1]
References
- ^ Rostami-Hodjegan A, Tucker GT (Feb 2007). "Simulation and prediction of in vivo drug metabolism in human populations from in vitro data". Nat Rev Drug Discov 6 (2): 140–8. doi:10.1038/nrd2173. PMID 17268485.
External links
http://www.simcyp.com
|